Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan

• Autori principali: Shigeki Nakamura (Autore), Masashi Mikami (Autore), Tomoyuki Hayamizu (Autore), Naohiro Yonemoto (Autore), Camille Moyon (Autore), Mark Gouldson (Autore), Catriona Crossan (Autore), Jeffrey Vietri (Autore), Kazumasa Kamei (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

ABSTRACTBackground The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is used in the Japanese National Immunization Program for older adults and adults with increased risk for pneumococcal disease, however, disease incidence and associated burden remain high. We evaluated the cost-effectiven...